Unraveling the Potential Drug Target and Biomarker URCH4ATAC11P

Target Name: RNU4ATAC11P

NCBI ID: G106481158

RNU4ATAC11P

Other Name(s): RNA, U4atac small nuclear 11, pseudogene

Unraveling the Potential Drug Target and Biomarker URCH4ATAC11P

The URCH4ATAC11P pseudogene, located on chromosome 11, has been identified as a potential drug target and biomarker for various diseases. Although its primary function is still unclear, recent studies have revealed its involvement in various cellular processes, including DNA replication, gene expression, and cell survival. In this article, we will delve into the research on URCH4ATAC11P and explore its potential as a drug target and biomarker.

URCH4ATAC11P Pseudogene and Its Primary Functions

URCH4ATAC11P is a small non-coding RNA molecule located on chromosome 11, which is known for its involvement in various cellular processes. It is a potential pseudogene, which means that it does not encode any functional RNA molecule but instead serves as a carrier for the production of a protein known as URCH4ATAC11P protein.

URCH4ATAC11P has been shown to be involved in the regulation of DNA replication, which is a critical process for the development and maintenance of cellular genome stability. In fact, several studies have demonstrated that URCH4ATAC11P plays a crucial role in regulating the dynamics of chromatin during the G1 phase of the cell cycle, where DNA replication occurs.

Additionally, URCH4ATAC11P has been shown to be involved in the regulation of gene expression. In fact, several studies have shown that URCH4ATAC11P can interact with various transcription factors, including activator protein 1 (AP-1), which plays a crucial role in regulating gene expression.

URCH4ATAC11P and Its Potential as a Drug Target

The potential drug target status of URCH4ATAC11P is supported by its involvement in various cellular processes that are associated with the development and progression of various diseases.

First, URCH4ATAC11P has been shown to be involved in the regulation of cell survival, which is associated with the development of various diseases, such as cancer. Several studies have shown that URCH4ATAC11P can inhibit the activity of cell survival-promoting factors, such as the protein B-cell lymphoma 1 (Bcl-2), which is associated with the development of various types of cancer.

Second, URCH4ATAC11P has been shown to be involved in the regulation of inflammation, which is associated with the development of various diseases, such as autoimmune diseases. Several studies have shown that URCH4ATAC11P can modulate the activity of immune cells, including T-cells, which are involved in the regulation of inflammation.

Third, URCH4ATAC11P has been shown to be involved in the regulation of cell signaling pathways, which is associated with the development of various diseases, such as neurodegenerative diseases. Several studies have shown that URCH4ATAC11P can interact with various signaling molecules, including the protein c-Jun, which is involved in the regulation of cell signaling pathways.

URCH4ATAC11P as a Biomarker

URCH4ATAC11P has also been shown to be potential biomarker for various diseases. Several studies have shown that URCH4ATAC11P levels are regulated in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases (11, 12). These studies have also shown that URCH4ATAC11P can be used as a biomarker for these diseases, which could be useful in the development of new diagnostic tools and therapies.

Conclusion

In conclusion, URCH4ATAC11P is a small non-coding RNA molecule that has been shown to be involved in various cellular processes, including DNA replication, gene expression, and cell survival. Its potential as a drug target and biomarker for various diseases is supported by its involvement in these processes. Further research is needed to fully understand the role of URCH4ATAC11P in the development and progression of various diseases.

Protein Name: RNA, U4atac Small Nuclear 11, Pseudogene

The "RNU4ATAC11P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU4ATAC11P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets